logo
Plus   Neg
Share
Email

U.S. Reaches Deal With Moderna For 100 Million Doses Of COVID-19 Vaccine

coronavirus feb18 12aug20

Moderna said Tuesday that it has reached an agreement with the U.S. to initially supply 100 million doses of its experimental vaccine for COVID-19, mRNA-1273. The U.S. government has awarded up to $1.525 billion for the vaccine.

The U.S. will also have the option to purchase up to an additional 400 million doses of mRNA-1273 from Moderna.

The U.S. government has already invested $955 million in the company's vaccine development, bringing its total investment up to $2.48 billion, Moderna said in a statement.

The U.S. has also entered into a deal with Pfizer in July to secure 100 million doses of its vaccine BNT162. In August it has reached a deal to get 100 million doses of vaccine Ad26.COV2.S from Janssen Pharmaceutical. Similarly, the U.S has reached deals with GlaxoSmithKline, Sanofi, Novavax and AstraZeneca for their vaccines.

For comments and feedback contact: editorial@rttnews.com

Health News

Follow RTT